Stay updated on Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5 on the page, indicating a new version of the ClinicalTrials.gov record. This reflects an internal update to the page rather than changes to study details or results.
    Difference
    0.1%
    Check dated 2026-08-08T18:19:25.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, signaling a new release of the page template or tooling; there are no visible content changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-25T10:46:32.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page’s revision tag changed from v3.6.2 to v3.6.3. This reflects a deployment/version update rather than a change to the page content.
    Difference
    0.1%
    Check dated 2026-07-03T22:00:02.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.2, replacing the previous v3.6.0. This indicates a newer revision of the page content and related materials.
    Difference
    0.1%
    Check dated 2026-06-26T23:46:11.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The page now includes new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the recruitment status to No longer looking for participants, indicating no current enrollment. A header formatting change and a revision label update are also present.
    Difference
    0.5%
    Check dated 2026-06-12T13:47:03.000Z thumbnail image
  9. Check
    82 days ago
    Change Detected
    Summary
    - The page revision was updated from v3.5.4 to v3.5.5, signaling a minor page-level update. No study content, eligibility criteria, or results information appear to have changed.
    Difference
    0.1%
    Check dated 2026-06-05T10:16:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.